Efficacy of Tocilizumab in Conventional Treatment-Refractory Adult-Onset Still's Disease: Multicenter Retrospective Open-Label Study of Thirty-Four Patients

Autor: Javier Rueda-Gotor, Alejandro Olivé, Inmaculada Ros Vilamajo, Ricardo Blanco, Jordi del Blanco, Vanesa Calvo-Río, José Llobet, Trinitario Pina, Mercedes Freire, M. Victoria Hernández, Sara Manrique Arija, Chamaida Plasencia-Rodríguez, Adela Gallego Flores, Santos Castañeda, Catalina Gómez Arango, Walter Alberto Sifuentes Giraldo, Carlos Marras, Miguel A. Caracuel, Miguel A. González-Gay, Francisco Ortiz-Sanjuán, M. Carmen González-Vela, María Luisa Velloso-Feijoó, C. Mata, Javier Narváez, Ana Urruticoechea, Concepción Moll-Tuduri, Esteban Rubio Romero, Javier Loricera, Rosa Roselló

Publikováno v: Arthritis & Rheumatology. 66:1659-1665

Objective Adult-onset Still's disease (AOSD) is frequently refractory to standard therapy. Tocilizumab (TCZ) has demonstrated efficacy in single cases and in small series of patients with AOSD. The aim of this multicenter study was to assess the effi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ceaf9aa72024c63555ba5c7b0527f718
https://doi.org/10.1002/art.38398

Volume 71 Table of Contents.

Publikováno v: Arthritis & Rheumatology; Dec2019, Vol. 71 Issue 12, p2138-2162, 25p

Identification of a 3′‐Untranslated Genetic Variant of RARB Associated With Carotid Intima‐Media Thickness in Rheumatoid Arthritis: A Genome‐Wide Association Study.

Autor: López‐Mejías, Raquel, Carmona, F. David, Genre, Fernanda, Remuzgo‐Martínez, Sara, González‐Juanatey, Carlos, Corrales, Alfonso, Vicente, Esther F., Pulito‐Cueto, Verónica, Miranda‐Filloy, José A., Ramírez Huaranga, Marco A., Blanco, Ricardo, Robustillo‐Villarino, Montserrat, Rodríguez‐Carrio, Javier, Alperi‐López, Mercedes, Alegre‐Sancho, Juan J., Mijares, Verónica, Lera‐Gómez, Leticia, Pérez‐Pampín, Eva, González, Antonio, Ortega‐Castro, Rafaela

Publikováno v: Arthritis & Rheumatology; Mar2019, Vol. 71 Issue 3, p351-360, 10p

Tocilizumab in refractory giant cell arteritis. Monotherapy versus combined therapy with conventional immunosuppressive drugs. Observational multicenter study of 134 patients.

Autor: Calderón-Goercke M; Departments of Rheumatology, Internal Medicine, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander. Universidad de Cantabria, Avda. Valdecilla s/n., ES- 39008, Santander, Spain., Castañeda S; Department of Rheumatology, Hospital Universitario de La Princesa, IIS-Princesa, Universidad Autónoma (UAM), Madrid, Cátedra UAM-Roche, EPID-Future, Madrid, Spain., Aldasoro V; Department of Rheumatology, Complejo Hospitalario de Navarra, Navarra, Spain., Villa I; Department of Rheumatology, Hospital de Sierrallana, Torrelavega, Cantabria, Spain., Moriano C; Department of Rheumatology, Complejo Asistencial Universitario de León, León, Spain., Romero-Yuste S; Department of Rheumatology, Complejo Hospitalario Universitario Pontevedra, Spain., Narváez J; Department of Rheumatology, Hospital de Bellvitge, Barcelona, Spain., Gómez-Arango C; Department of Rheumatology, Hospital Alto Deba, Mondragón, Spain., Pérez-Pampín E; Department of Rheumatology, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain., Melero R; Department of Rheumatology, Complexo Hospitalario Universitario de Vigo, Vigo, Spain., Becerra-Fernández E; Department of Rheumatology, Hospital Universitario de Torrevieja, Alicante, Spain., Revenga M; Department of Rheumatology, Hospital Ramón y Cajal, Madrid, Spain., Álvarez-Rivas N; Department of Rheumatology, Hospital Universitario Lucus Augusti, Lugo, Spain., Galisteo C; Department of Rheumatology, Hospital Parc Taulí, Barcelona, Spain., Sivera F; Department of Rheumatology, Hospital Universitario de Elda, Alicante, Spain., De Miguel E; Department of Rheumatology, Hospital La Paz, Madrid, Spain., Prieto-Peña D; Departments of Rheumatology, Internal Medicine, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander. Universidad de Cantabria, Avda. Valdecilla s/n., ES- 39008, Santander, Spain., González-Gay MÁ; Departments of Rheumatology, Internal Medicine, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander. Universidad de Cantabria, Avda. Valdecilla s/n., ES- 39008, Santander, Spain., Hernández JL; Departments of Rheumatology, Internal Medicine, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander. Universidad de Cantabria, Avda. Valdecilla s/n., ES- 39008, Santander, Spain. Electronic address: joseluis.hernandez@scsalud.es., Blanco R; Departments of Rheumatology, Internal Medicine, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander. Universidad de Cantabria, Avda. Valdecilla s/n., ES- 39008, Santander, Spain.

Publikováno v: Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2021 Apr; Vol. 51 (2), pp. 387-394. Date of Electronic Publication: 2021 Jan 27.